Stéphane Culine

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.

Philippe Rougier, R. Bugat, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 1997 · 433 citations

Medicine, Oncology, Pharmacology +14

Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer: ELCAPA Study

Philippe Caillet, Florence Canouï‐Poitrine, Johanna Vouriot et al. · Journal of Clinical Oncology · 2011 · 419 citations · Full text

Medicine, Geriatric Medicine, Oncology +15

Viable Malignant Cells After Primary Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors: Prognostic Factors and Role of Postsurgery Chemotherapy—Results From an International Study Group

Karim Fizazi, Sergei Tjulandin, Roberto Salvioni et al. · Journal of Clinical Oncology · 2001 · 280 citations

Medicine, Oncology, Surgery +15

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

S. Krege, Rainer Souchon, Peter Albers et al. · European Urology · 2008 · 252 citations

Medicine, Cancer Biology, Oncology +17